Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment
Recruiting
N/A
Interventional Study
Mild Cognitive Impairment (MCI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 160 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment to reduce their NPS, and to investigate the feasibility and effectiveness of the intervention.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Community-dwelling adults aged ≥ 50 years
* HK-MoCA score ranged from 18 to 22
* MBI-C ≥7
* SCD-9 ≥3
* IADL =18
* Able to read and communicate in Chinese
* Able to use the text or voice messaging function on a smartphone
Exclusion Criteria:
* Clinical diagnosis of dementia
*…
Contacts